2009-06-BOS-min - Laserfiche WebLink

Browse Search

65-422 Selectmen’s Meeting June 8, 2009 A regular meeting of the Board of Selectmen was held on Monday, June 8, 2009 at 7:30 p.m. in the Selectmen Meeting Room, Town Office Building. Chairman Cohen, Mrs. Krieger, Mr. Kelley, Mr. Manz and Mr. Burnell; Mr. Valente, Town Manager; and Ms. Pease, Executive Clerk, were present. Public Comments Mr. Borenstein, 60 Lowell Street, wants to make sure his and his neighbors concerns regarding the purchase of the Busa property are addressed prior to the Purchase and Sale Agreement being approved. Mr. Cohen asked them to bring their concerns to either Selectmen or Town Manager. Mr. Johnson, President of the Board of the Lexington Symphony, wanted the Selectmen to be aware that the Lexington Symphony has been asked to do a concert in Boston while the tall ships are in town, which would be an extraordinary opportunity for Lexington to get exposure. If there is a concert $20,000 will need to be raised. The Tourism Committee is willing to help find some of the necessary funds and they are looking for sponsors. Selectmen Concerns and Liaison Reports All of the Selectmen attended the Lexington High School graduation over the weekend. Mr. Manz felt it was a reminder of why he lives in Lexington. CD Rezoning Proposal Cubist Pharmaceuticals, represented by Robert Buckley, Senior Partner with the law firm of Riemer and Braunstein; Mike Bonney, CEO, Cubist Pharmaceuticals; and David McGirr, Senior Vice President and Chief Financial Officer for Cubist Pharmaceuticals came before the Selectmen to discuss their plan to expand Cubist’s operation by 100,000 square feet by adding additional stories on to the existing building. They are commencing review of the site constraints, looking at preliminary designs and then will come before the necessary town boards and departments to discuss issues and start the process over the next few months. Mr. Bonney has been with Cubist since 2001. Cubist is a self-sustaining biotechnology company that focuses on diseases of the acutely ill and was founded on the new technology of antibiotics. They expect that this year revenue will grow 30 percent and that allows them to expand the Hayden Avenue operation and continue the search for new antibiotics, which will be very important in killing new bacteria. Cubist has grown from 130 employees in 2001 to 400 in 2009 and they expect to continue to expand. Last month they were named number one in the Boston Globe’s annual 100 best companies in Massachusetts. Mrs. Krieger believes this is the type of business Lexington likes to see and it fits nicely as Lexington tries to establish itself as the center of biotech and pharmaceutical development.